# Palliative Stereotactic Body Radiation Therapy for the Treatment of Refractory Ventricular Tachycardia

## TL;DR

Stereotactic body radiation therapy (SBRT) is explored as a noninvasive treatment for refractory ventricular tachycardia in patients unsuitable for traditional interventions.

## Contribution

This paper presents a novel palliative application of SBRT for treating refractory ventricular tachycardia in high-risk patients.

## Key findings

- A 62-year-old patient with refractory VT experienced reduced VT episodes after SBRT.
- SBRT is a viable option for patients ineligible for invasive procedures due to high-risk profiles and comorbidities.

## Abstract

Stereotactic body radiation therapy (SBRT) is a promising noninvasive treatment for ventricular tachycardia (VT) that delivers targeted ablative energy to arrhythmogenic regions. Typically reserved for patients with VT refractory to conventional therapies, SBRT offers a viable option for individuals who are ineligible for invasive procedures due to high-risk profiles and multiple comorbidities. We report the case of a 62-year-old patient with refractory VT, deemed unsuitable for further interventions, who underwent SBRT and experienced a reduction in VT episodes. This case highlights the potential palliative application of SBRT in addressing the growing population of older patients with complex comorbid conditions.